ArticleJournal of oncology2022

Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma.

Zhenxing Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.